These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 17418276)

  • 21. What is the impact of tamoxifen on radiation-induced fibrosis in patients receiving breast-conserving therapy.
    Koc M
    J Clin Oncol; 2007 Dec; 25(36):5841; author reply 5844-5. PubMed ID: 18089889
    [No Abstract]   [Full Text] [Related]  

  • 22. Tamoxifen in breast cancer: not so easy to write off.
    Munshi A; Singh P
    Breast; 2008 Apr; 17(2):121-4. PubMed ID: 17923407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mesenteric fibromatosis: a report of three cases and literature review.
    Kabra V; Chaturvedi P; Pathak KA; deSouza LJ
    Indian J Cancer; 2001; 38(2-4):133-6. PubMed ID: 12593452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Medical treatment of a voluminous tumor of the mesenteric root].
    Boisselier P; Foucher F; Boucher E; Raoul JL
    Gastroenterol Clin Biol; 2003 Apr; 27(4):428. PubMed ID: 12759690
    [No Abstract]   [Full Text] [Related]  

  • 25. Is tamoxifen an option for patients with endometrial stromal sarcoma?
    Reich O; Regauer S
    Gynecol Oncol; 2005 Feb; 96(2):561; author reply 561. PubMed ID: 15661256
    [No Abstract]   [Full Text] [Related]  

  • 26. CYP2D6 genotyping and the pharmacogenetics of tamoxifen.
    Flockhart D
    Clin Adv Hematol Oncol; 2008 Jul; 6(7):493-4. PubMed ID: 18654115
    [No Abstract]   [Full Text] [Related]  

  • 27. By the way, doctor. Should I switch from tamoxifen to an aromatase inhibitor?
    Robb-Nicholson C
    Harv Womens Health Watch; 2007 Jun; 14(10):8. PubMed ID: 18018318
    [No Abstract]   [Full Text] [Related]  

  • 28. [Tamoxifen in the adjuvant setting for breast cancer: Reflexions about the risk of uterine carcinosarcoma].
    Leung F; Terzibachian JJ; Govyadovskiy A; Bourtembourg A; Maillet R; Riethmuller D
    Gynecol Obstet Fertil; 2009 May; 37(5):447-51. PubMed ID: 19394886
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful treatment of retroperitoneal fibrosis with tamoxifen in a child.
    Dedeoglu F; Rose CD; Athreya BH; Conard K; Grissom L; Magnusson M
    J Rheumatol; 2001 Jul; 28(7):1693-5. PubMed ID: 11469481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The optimal duration of adjuvant hormonal therapy for early-stage breast cancer.
    Winer E
    Clin Adv Hematol Oncol; 2008 Aug; 6(8):573-4. PubMed ID: 18820598
    [No Abstract]   [Full Text] [Related]  

  • 31. Potential role of the steroid receptor pattern in the response of inoperable intra-abdominal desmoid to toremifene after failure of tamoxifen therapy.
    Altomare DF; Rotelli MT; Rinaldi M; Bocale D; Lippolis C; Lobascio P; Cavallini A
    Int J Colorectal Dis; 2010 Jun; 25(6):787-9. PubMed ID: 20012438
    [No Abstract]   [Full Text] [Related]  

  • 32. Do some antidepressants decrease effect of tamoxifen?
    J Support Oncol; 2009; 7(4):147-8. PubMed ID: 19731582
    [No Abstract]   [Full Text] [Related]  

  • 33. Controversies in the management of patients with breast cancer: adjuvant endocrine therapy in premenopausal women.
    Parton M; Smith IE
    J Clin Oncol; 2008 Feb; 26(5):745-52. PubMed ID: 18258982
    [No Abstract]   [Full Text] [Related]  

  • 34. Fatal Outcome of Recurrent Infantile Pelvic Desmoid Tumor Treated with Tamoxifene.
    Amaadour L; Benbrahim Z; Zouiten O; Bourdi N; Alaoui YL; El Mazti A; Hammas N; Mellas N
    Gulf J Oncolog; 2018 Jan; 1(26):75-78. PubMed ID: 29607829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical significance of CYP2D6 polymorphisms and tamoxifen in women with breast cancer.
    Gaston C; Kolesar J
    Clin Adv Hematol Oncol; 2008 Nov; 6(11):825-33. PubMed ID: 19194367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Possible therapeutic role of vitamin D3 in aggressive fibromatosis.
    Ferah Y; Ayse K; Mustafa C; Ugur S; Murat G; Lale AI
    Jpn J Clin Oncol; 2004 Aug; 34(8):472-5. PubMed ID: 15371466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Choices and challenges in endocrine treatment for breast cancer.
    Murta EF; Nomelini RS
    Int J Clin Pract; 2007 Dec; 61(12):1962-4. PubMed ID: 17997799
    [No Abstract]   [Full Text] [Related]  

  • 38. Pathology quiz case. Fibromatosis (desmoid tumor) of the neck.
    Hsu YB; Li WY; Lan MC; Chu PY
    Arch Otolaryngol Head Neck Surg; 2008 May; 134(5):559, 560-1. PubMed ID: 18490583
    [No Abstract]   [Full Text] [Related]  

  • 39. Tamoxifen-induced ultraviolet, recall dermatitis.
    Ledet JJ; Grafton LH
    J Drugs Dermatol; 2009 Aug; 8(8):761-2. PubMed ID: 19663115
    [No Abstract]   [Full Text] [Related]  

  • 40. The ethics of CYP2D6 testing for patients considering tamoxifen.
    Hartman AR; Helft P
    Breast Cancer Res; 2007; 9(2):103. PubMed ID: 17433116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.